Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melvyn T Chow

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Immunity|May 18, 2019
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 TherapyMelvyn T Chow, Aleksandra J Ozga, Rachel L Servis, et al.
Nature Immunology|March 25, 2014
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functionsChristopher J Chan, Ludovic Martinet, Susan Gilfillan, et al.
Immunology and Cell Biology|January 26, 2011
Homeostatic defects in interleukin 18-deficient mice contribute to protection against the lethal effects of endotoxinDaniel M Andrews, Melvyn T Chow, Yuting Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2013
Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cellsLiza B John, Christel Devaud, Connie P M Duong, et al.
Cancer Research|July 4, 2012
Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic nicheJaclyn Sceneay, Melvyn T Chow, Anna Chen, et al.
Nature Medicine|October 27, 2014
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapyAntonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Immunity|May 18, 2019
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 TherapyMelvyn T Chow, Aleksandra J Ozga, Rachel L Servis, et al.
Nature Immunology|March 25, 2014
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functionsChristopher J Chan, Ludovic Martinet, Susan Gilfillan, et al.
Immunology and Cell Biology|January 26, 2011
Homeostatic defects in interleukin 18-deficient mice contribute to protection against the lethal effects of endotoxinDaniel M Andrews, Melvyn T Chow, Yuting Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2013
Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cellsLiza B John, Christel Devaud, Connie P M Duong, et al.
Cancer Research|July 4, 2012
Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic nicheJaclyn Sceneay, Melvyn T Chow, Anna Chen, et al.
Nature Medicine|October 27, 2014
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapyAntonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, et al.
Pageof 2